Metallothioneins and neurodegenerative diseases

Isao Hozumi, Masato Asanuma, Mitsunori Yamada, Yoko Uchida

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

A symposium on the clinical aspects of metallothioneins (MTs) in neurodegenerative diseases was held at the 2003 Society of Metallothionein Meeting in Gifu, Japan. The objectives of the symposium were to review and speculate on the potential roles of MTs, especially MT-3 in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and spinocerebellar degeneration (SCD). Dr. Uchida discussed the controversial problem regarding the expression of MT-3 in AD brains. Dr. Asanuma addressed the function of MTs in the progression of PD and Dr. Hozumi described the therapeutic potential of MTs for ALS, while Dr. Yamada provided immunohistochemical findings of MT-3 in SCD for the first time. Although there are still controversial problems on MTs, this review provides proof that MTs are promising potential therapeutic targets for therapy for some neurodegenerative diseases.

Original languageEnglish
Pages (from-to)323-331
Number of pages9
JournalJournal of Health Science
Volume50
Issue number4
DOIs
Publication statusPublished - Aug 2004

Fingerprint

Neurodegenerative diseases
Metallothionein
Neurodegenerative Diseases
Spinocerebellar Degenerations
Amyotrophic Lateral Sclerosis
Parkinson Disease
Japan
Alzheimer Disease
Therapeutics
Brain

Keywords

  • Alzheimer's disease
  • Amyotrophic lateral sclerosis
  • Growth inhibitory factor
  • Metallothionein
  • Neurodegenerative disease

ASJC Scopus subject areas

  • Toxicology
  • Health, Toxicology and Mutagenesis

Cite this

Metallothioneins and neurodegenerative diseases. / Hozumi, Isao; Asanuma, Masato; Yamada, Mitsunori; Uchida, Yoko.

In: Journal of Health Science, Vol. 50, No. 4, 08.2004, p. 323-331.

Research output: Contribution to journalArticle

Hozumi, Isao ; Asanuma, Masato ; Yamada, Mitsunori ; Uchida, Yoko. / Metallothioneins and neurodegenerative diseases. In: Journal of Health Science. 2004 ; Vol. 50, No. 4. pp. 323-331.
@article{b3180aa83114434b8f2c67b212bfea5c,
title = "Metallothioneins and neurodegenerative diseases",
abstract = "A symposium on the clinical aspects of metallothioneins (MTs) in neurodegenerative diseases was held at the 2003 Society of Metallothionein Meeting in Gifu, Japan. The objectives of the symposium were to review and speculate on the potential roles of MTs, especially MT-3 in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and spinocerebellar degeneration (SCD). Dr. Uchida discussed the controversial problem regarding the expression of MT-3 in AD brains. Dr. Asanuma addressed the function of MTs in the progression of PD and Dr. Hozumi described the therapeutic potential of MTs for ALS, while Dr. Yamada provided immunohistochemical findings of MT-3 in SCD for the first time. Although there are still controversial problems on MTs, this review provides proof that MTs are promising potential therapeutic targets for therapy for some neurodegenerative diseases.",
keywords = "Alzheimer's disease, Amyotrophic lateral sclerosis, Growth inhibitory factor, Metallothionein, Neurodegenerative disease",
author = "Isao Hozumi and Masato Asanuma and Mitsunori Yamada and Yoko Uchida",
year = "2004",
month = "8",
doi = "10.1248/jhs.50.323",
language = "English",
volume = "50",
pages = "323--331",
journal = "Journal of Health Science",
issn = "1344-9702",
publisher = "Pharmaceutical Society of Japan",
number = "4",

}

TY - JOUR

T1 - Metallothioneins and neurodegenerative diseases

AU - Hozumi, Isao

AU - Asanuma, Masato

AU - Yamada, Mitsunori

AU - Uchida, Yoko

PY - 2004/8

Y1 - 2004/8

N2 - A symposium on the clinical aspects of metallothioneins (MTs) in neurodegenerative diseases was held at the 2003 Society of Metallothionein Meeting in Gifu, Japan. The objectives of the symposium were to review and speculate on the potential roles of MTs, especially MT-3 in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and spinocerebellar degeneration (SCD). Dr. Uchida discussed the controversial problem regarding the expression of MT-3 in AD brains. Dr. Asanuma addressed the function of MTs in the progression of PD and Dr. Hozumi described the therapeutic potential of MTs for ALS, while Dr. Yamada provided immunohistochemical findings of MT-3 in SCD for the first time. Although there are still controversial problems on MTs, this review provides proof that MTs are promising potential therapeutic targets for therapy for some neurodegenerative diseases.

AB - A symposium on the clinical aspects of metallothioneins (MTs) in neurodegenerative diseases was held at the 2003 Society of Metallothionein Meeting in Gifu, Japan. The objectives of the symposium were to review and speculate on the potential roles of MTs, especially MT-3 in neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS) and spinocerebellar degeneration (SCD). Dr. Uchida discussed the controversial problem regarding the expression of MT-3 in AD brains. Dr. Asanuma addressed the function of MTs in the progression of PD and Dr. Hozumi described the therapeutic potential of MTs for ALS, while Dr. Yamada provided immunohistochemical findings of MT-3 in SCD for the first time. Although there are still controversial problems on MTs, this review provides proof that MTs are promising potential therapeutic targets for therapy for some neurodegenerative diseases.

KW - Alzheimer's disease

KW - Amyotrophic lateral sclerosis

KW - Growth inhibitory factor

KW - Metallothionein

KW - Neurodegenerative disease

UR - http://www.scopus.com/inward/record.url?scp=24744431646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24744431646&partnerID=8YFLogxK

U2 - 10.1248/jhs.50.323

DO - 10.1248/jhs.50.323

M3 - Article

VL - 50

SP - 323

EP - 331

JO - Journal of Health Science

JF - Journal of Health Science

SN - 1344-9702

IS - 4

ER -